000 01489 a2200385 4500
005 20250517164912.0
264 0 _c20180627
008 201806s 0 0 eng d
022 _a1520-7560
024 7 _a10.1002/dmrr.2925
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDi Tomo, Pamela
245 0 0 _aLiraglutide mitigates TNF-α induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women.
_h[electronic resource]
260 _bDiabetes/metabolism research and reviews
_c11 2017
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAtherosclerosis
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHuman Umbilical Vein Endothelial Cells
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aIntercellular Adhesion Molecule-1
_xmetabolism
650 0 4 _aLiraglutide
_xpharmacology
650 0 4 _aOxidative Stress
_xdrug effects
650 0 4 _aTumor Necrosis Factor-alpha
_xpharmacology
650 0 4 _aVascular Cell Adhesion Molecule-1
_xmetabolism
700 1 _aLanuti, Paola
700 1 _aDi Pietro, Natalia
700 1 _aBaldassarre, Maria Pompea Antonia
700 1 _aMarchisio, Marco
700 1 _aPandolfi, Assunta
700 1 _aConsoli, Agostino
700 1 _aFormoso, Gloria
773 0 _tDiabetes/metabolism research and reviews
_gvol. 33
_gno. 8
856 4 0 _uhttps://doi.org/10.1002/dmrr.2925
_zAvailable from publisher's website
999 _c27411838
_d27411838